Circulating hepatocyte growth factor as a marker of thrombus formation in unstable angina pectoris

被引:9
作者
Matsumori, A
Miyazaki, S
Takano, H
Ono, K
Okada, M
Miyamoto, T
Nonogi, H
Daikoku, S
Mitsudo, K
Matsunaga, Y
Ohnishi, T
Daikuhara, Y
Sasayama, S
机构
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068397, Japan
[2] Natl Cardiovasc Ctr, Suita, Osaka 565, Japan
[3] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[4] Kagoshima Univ, Sch Dent, Dept Biochem, Kagoshima 890, Japan
来源
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION | 2000年 / 64卷 / 10期
关键词
hepatocyte growth factor; thrombosis; unstable angina;
D O I
10.1253/jcj.64.805
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
A new enzyme-linked immunosorbent assay can detect 10 pg/ml of human hepatocyte growth factor (HGF). Circulating HGF was significantly higher in patients with unstable angina (296+/-184 pg/ml, mean+/-SD, n=36) than in healthy volunteers (201+/-64 pg/ml, n=250, p<0.0001). Individual concentrations exceeded the mean control value +2 SD (329 pg/ml) in 12 of the 36 (33%) patients with unstable angina. The present study indicates that this new, sensitive HGF assay can successfully detect thrombosis in patients with unstable angina.
引用
收藏
页码:805 / 807
页数:3
相关论文
共 10 条
[1]  
BRAUNWALD E, 1994, CIRCULATION, V89, P1545
[2]   UNSTABLE ANGINA - A CLASSIFICATION [J].
BRAUNWALD, E .
CIRCULATION, 1989, 80 (02) :410-414
[3]   Circulating hepatocyte growth factor as an early marker of arterial thrombus formation [J].
Matsumori, A ;
Ono, K ;
Furukawa, Y ;
Okada, M ;
Sasayama, S .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1998, 62 (04) :311-313
[4]   Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction [J].
Matsumori, A ;
Furukawa, Y ;
Hashimoto, T ;
Ono, K ;
Shioi, T ;
Okada, M ;
Iwasaki, A ;
Nishio, R ;
Sasayama, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (02) :391-395
[5]  
Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591
[6]   Cardiac troponin T levels for risk stratification in acute myocardial ischemia [J].
Ohman, EM ;
Armstrong, PW ;
Christenson, RH ;
Granger, CB ;
Katus, HA ;
Hamm, CW ;
OHanesian, MA ;
Wagner, GS ;
Kleiman, NS ;
Harrell, FE ;
Califf, RM ;
Topol, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) :1333-1341
[7]   Enhanced expression of hepatocyte growth factor c-Met by myocardial ischemia and reperfusion in a rat model [J].
Ono, K ;
Matsumori, A ;
Shioi, T ;
Furukawa, Y ;
Sasayama, S .
CIRCULATION, 1997, 95 (11) :2552-2558
[8]   Is hepatocyte growth factor a protein with cardioprotective activity in the ischemic heart? [J].
Schaper, W ;
Kubin, T .
CIRCULATION, 1997, 95 (11) :2471-2472
[9]  
TSUBOUCHI H, 1991, HEPATOLOGY, V13, P1
[10]   PREHOSPITAL-INITIATED VS HOSPITAL-INITIATED THROMBOLYTIC THERAPY - THE MYOCARDIAL-INFARCTION TRIAGE AND INTERVENTION TRIAL [J].
WEAVER, WD ;
CERQUEIRA, M ;
HALLSTROM, AP ;
LITWIN, PE ;
MARTIN, JS ;
KUDENCHUK, PJ ;
EISENBERG, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (10) :1211-1216